Rtog-1308: Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy For Inoperable Stage II-IIIb Nsclc
Posted Date: Sep 28, 2020
- Investigator: Emily Daugherty
- Specialties: Cancer, Lung Cancer, Oncology, Pulmonary Diseases, Radiation Oncology
- Type of Study: Device
To compare the overall survival (OS) in patients with stage II-IIIB NSCLC Photon (X-Ray) radiation therapy (Arm 1) versus Proton radiation therapy (Arm 2) both given with concurrent platinum-based chemotherapy
Criteria:
Newly Diagnosed Stage Ii To Stage Iiib Non-Small Cell Lung Cancer Which Is Not Surgically Removed
Keywords:
Proton Therapy, Lung Cancer, Radiation Therapy
For More Information:
Dr. Emily Daugherty, Md
513-584-4073
daugheec@ucmail.uc.edu